Stay updated on Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.

Latest updates to the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMinor administrative updates: the page revision is updated to v3.4.2 and the previous funding/status notices are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotices about government funding lapse and NIH operating status were added, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include showing the glossary option, adding the label 'Last Update Submitted that Met QC Criteria,' capitalization adjustment for 'No FEAR Act Data,' and a new revision reference (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated to v3.3.4 (replacing the previous v3.3.3) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section listing Pennsylvania as the study site; removed the separate 'Pennsylvania Locations' entry and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedMinor wording updates: the additions clarify that publications are automatically filled from PubMed and note Revision: v3.3.2, while the deletions indicate PubMed-derived data and list Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.